We have previously demonstrated that a plasma natriuretic factor is present
in Alzheimer's disease (AD), but not in multi-infarct dementia (MID) or no
rmal controls (C). We postulated that the natriuretic factor might induce t
he increased cytosolic calcium reported in AD by inhibiting the sodium-calc
ium antiporter, thereby activating the apoptotic pathway. To test for a fac
tor in AD plasma that induces apoptosis, we exposed nonconfluent cultured L
LC-PK1 cells to plasma from AD, MID, and C for 2 h and performed a terminal
transferase-dUTP-nick-end labeling (TUNEL) assay. The plasma from AD incre
ased apoptosis nearly fourfold compared with MID and C. The effect was dose
dependent and the peak effect was attained after a 2-h exposure. Additiona
lly, apoptotic morphology was detected by electron microscopy, and internuc
leosomal DNA cleavage was found. We inhibited apoptosis by removing calcium
from the medium, inhibiting protein synthesis with cycloheximide, alternat
ely boiling or freezing and thawing the plasma, and digesting a partially p
urified fraction with trypsin. Heating AD plasma to 56 degrees C did not de
activate the apoptotic factor. These results demonstrate the presence of an
apoptotic factor in the plasma of patients with AD.